GLUCAGON-LIKE PEPTIDE-1 AGONISTS These subcutaneous injectable medications are effective for weight loss and aid in treating type 2 diabetes
346 In parallel, modulation of microbial metabolites offers therapeutic leverage: promoting beneficial compounds such as 3-IAA, which enhances ROS and chemosensitivity, or suppressing lactate-secreting strains such as Lactobacillus iners may reverse resistance-associated metabolic reprogramming
Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents
Lately, GLP-1 drugs have emerged as a promising option
Plus, Ana Maria Kausel, MD, a board-certified endocrinologist in Miami, says stimulants like Vyvanse put the body in a fight or flight response, hence suppressing appetite and increasing the metabolism. In 2015, the FDA approved Vyvanse to be used in the treatment of binge eating disorder